Mounjaro 10 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FML1W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,982
Award facts
- Contract value 100% obligated
- $11,982.29 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,982.29 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 mL pens (0.5 mL) under a firm fixed-price contract. The award was made on February 4, 2026, with an ultimate completion date of February 5, 2026, and performance to be fulfilled at the contractor's Conshohocken, Pennsylvania location. This delivery order represents a non-set-aside procurement, indicating the award was made through open competition. Mounjaro is a diabetes medication, consistent with AmerisourceBergen's extensive portfolio of pharmaceutical deliveries to federal medical supply chains.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which serves as the parent organization. The IDC functions as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices to support military healthcare programs worldwide. This contract vehicle demonstrates the contractor's established capability to efficiently meet federal medical procurement requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FML1W?
SPE2DR26FML1W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26FML1W worth?
The government has obligated $11,982 on SPE2DR26FML1W.
Is contract SPE2DR26FML1W an order under another contract?
Yes. SPE2DR26FML1W is a delivery order under SPE2DR25D1200, an indefinite delivery contract.
Was contract SPE2DR26FML1W competed?
The extent of competition for SPE2DR26FML1W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award